Skip to main content
OpenTrials
Completed

NCT Number: NCT01834131

Hypertension Control Program in Argentina (HCPIA)

The objective of this cluster randomized trial is to test whether a comprehensive intervention program within a national public primary care system will improve hypertension control among uninsured hypertensive patients and their families in Argentina.

Completed

Looking for future studies?

Notify Me

Key information

Age range

21 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Institute for Clinical Effectiveness and Health Policy

Buenos Aires, C1414CPV, Argentina

About this study

Background: Although the efficacy and effectiveness of lifestyle modifications and antihypertensive pharmaceutical treatment for the prevention and control of hypertension and concomitant cardiovascular disease and premature death have been demonstrated in randomized controlled trials, this scientific knowledge has not been fully applied in the general population, especially in low and middle income countries.

Objectives: To test whether a comprehensive intervention program within a national public primary care system will improve hypertension control among uninsured hypertensive patients and their families in Argentina

Design: Cluster randomized trial

Study Participants: 1,890 study participants from 18 primary care clinics within a public primary care network in Argentina will be recruited. Patients with hypertension from the participating clinics, their spouses, and their adult hypertensive family members will be enrolled.

Intervention: Nine clinics with approximately 945 participants will be randomly assigned to the comprehensive intervention group and 9 clinics with similar participants to the usual care group. The comprehensive intervention, including health care provider education, a home-based intervention among patients and their families (lifestyle modification and home blood pressure [BP] monitoring) delivered by community health workers, and a mobile health intervention, will last for 18 months.

Outcomes: BP and other indicators will be measured at baseline and months 6, 12, and 18 during follow-up using standard methods. The primary outcome is a net change in systolic (SBP) and diastolic BP (DBP) from baseline to month 18 between the intervention and control groups among hypertensive study participants. The secondary outcomes are the proportion of hypertensive patients with adequate BP control (BP<140/90 mmHg), cost-effectiveness of hypertension control, and net BP changes in normotensive participants.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

for Clinics:

  • The clinic is affiliated with the Remediar+Redes program.
  • The clinic is located in urban poor areas according to the 2010 census data.
  • The clinic has ≥1000 outpatient visits each month, so that sufficient participants can be recruited.
  • The minimum distance between the selected clinics will be 10 kilometers to minimize the risk for contamination of the intervention.
  • Physician visits and essential medications are free of charge to patients under all circumstances.
  • The clinic has a high number of prescriptions for antihypertensive medications.
  • The clinic employs community health workers.
  • The clinic has general practitioners and nurses.
  • The clinic has a history of good performance in the Remediar+Redes program.
  • The clinic performs blood draws on patients when appropriate.

Inclusion criteria

for Participants:

  • Patients aged ≥21 years who received primary care from the participating clinics and have hypertension ( SBP ≥140 mmHg and/or DBP ≥90 mmHg on at least 2 separate visits) and their spouses (with or without hypertension) and/or any adult hypertensive family members (age ≥21 years) living in the same household will be included.
  • Hypertension patients and their spouses and/or family members must be available for the first baseline nurse home visit.
  • The index patient must have a cell phone that receives text messages.
  • The family's homes must be located within 10 kilometers from the clinic.

Exclusion criteria

for Participants:

  • Hypertension patients who do not have a spouse or another adult with hypertension in the household.
  • Plans to move from the neighborhood in the next two years
  • Pregnant women or women who are planning to become pregnant in the next two years
  • Persons who are bed-bound
  • Persons who cannot give informed consent
  • Persons with an arm circumference >50 cm

Treatment and study plan

Comprehensive intervention

Behavioral

The comprehensive intervention includes physician education, a community health worker home intervention and a mobile health intervention. Please see Arm Description for details.

Primary outcomes

  1. Net change in systolic (SBP) and diastolic BP (DBP) from baseline to month 18 between the intervention and control groups among hypertensive study participants.

    Time frame: Baseline and 18 months

    Three BP measurements will be obtained at each data collection visit by study nurses who are masked to clinic assignment. BP will be measured according to a standard protocol recommended by the American Heart Association. The average of the three measurements will be used to compare the change over 18 months between the intervention and control groups.

Secondary outcomes

  1. Proportion of hypertension control (BP<140/90 mmHg) among hypertensive patients

    Time frame: Baseline and 18 months

    The proportion of hypertensives with blood pressure control (defined as (BP<140/90 mmHg or < 130/80 mmHg if patient has diabetes of CKD) will be compared between the intervention and control group.

  2. Self-reported medication adherence among hypertensive patients

    Time frame: Baseline and 18 months

    The Morisky scale questionnaire will be administered at baseline and 18 months of follow-up to compare medication adherence between the intervention and control groups.

  3. Cost-effectiveness of the intervention

    Time frame: Baseline and 18 Months

    All resources involved in conducting this comprehensive intervention program, as well as all patient-level costs, will be documented. Primary incremental cost effectiveness ratio (ICER) measure will be cost per mmHg of change in SBP and DBP.

  4. Net change in systolic (SBP) and diastolic BP (DBP) from baseline to month 18 between the intervention and control groups among normotensive study participants

    Time frame: Baseline and 18 months

    Three BP measurements will be obtained at each data collection visit by study nurses who are masked to clinic assignment. BP will be measured according to a standard protocol recommended by the American Heart Association. The average of the three measurements will be used to compare the change over 18 months between the intervention and control groups among normotensives.

  5. Net change in body weight and waist circumference from baseline to 18 months

    Time frame: Baseline and 18 months

    Study nurses will take anthropometric measurements on individuals in light clothing without shoes using a standard protocol.

  6. Intensity of treatment

    Time frame: Baseline and 18 months

    Intensification (titration and/or addition) of antihypertensive medications,compared between the intervention and control groups after 18 months of follow-up.

Sponsors and collaborators

Lead sponsor

Tulane University

Other

Collaborators

  • Institute for Clinical Effectiveness and Health Policy
  • National Heart, Lung, and Blood Institute (NHLBI)

Registry information

Official study title

Comprehensive Approach for Hypertension Prevention and Control in Argentina

Important dates

Study start
2013
Primary completion
2016
Study completion
2016
First posted
Apr 17, 2013
Registry last updated
Jul 17, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.